GENE ONLINE|News &
Opinion
Blog

CDMO
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
Catalent Scoops Up Fellow CDMO, Metrics, for $475 Million
2022-08-11
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Lonza Signs CDMO Deal to Break Into Israeli Market
2022-05-25
LOTTE Corporation Buys Bristol Myers Squibb’s New York Manufacturing Plant for $160 Million
2022-05-16
Bora Pharmaceuticals Expands with Eden Biologics’ CDMO Purchase
2022-05-11
Asahi Kasei Medical Ups CDMO Business in the US with Bionova Buy
2022-04-21
HCmed and Formosa Laboratories Join Forces to Create CDMO for Inhaled Drugs
2022-03-08
AbClon, HK inno.N Collaborates to Take On Novartis’ CAR T-Cell Therapy
2022-02-15
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
Fujifilm Expands CDMO Operations by Buying Atara’s Cell Therapy Plant for $100 Million
2022-01-27
South Korea’s SK Inc., Develops Its CDMO Capabilities via Investment in the Center for Breakthrough Medicines
2022-01-21
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
1 2 3
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top